Hamilton Lane Advisors’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3
| Closed | – | – | 52 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 47 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 51 |
|
|
2017
Q4 | $12K | Hold |
3
| – | – | 0.01% | 55 |
|
|
2017
Q3 | $22K | Hold |
3
| – | – | 0.02% | 50 |
|
|
2017
Q2 | $13K | Hold |
3
| – | – | 0.01% | 51 |
|
|
2017
Q1 | $15K | Hold |
3
| – | – | 0.01% | 59 |
|
|
2016
Q4 | $18K | Hold |
3
| – | – | 0.01% | 63 |
|
|
2016
Q3 | $41K | Hold |
3
| – | – | 0.02% | 60 |
|
|
2016
Q2 | $52K | Hold |
3
| – | – | 0.03% | 57 |
|
|
2016
Q1 | $56K | Hold |
3
| – | – | 0.03% | 55 |
|
|
2015
Q4 | $55K | Hold |
3
| – | – | 0.02% | 48 |
|
|
2015
Q3 | $54K | Hold |
3
| – | – | 0.03% | 48 |
|
|
2015
Q2 | $68K | Hold |
3
| – | – | 0.03% | 60 |
|
|
2015
Q1 | $52K | Hold |
3
| – | – | 0.02% | 51 |
|
|
2014
Q4 | $35K | Buy |
+3
| New | +$35K | 0.01% | 51 |
|
|
2014
Q3 | – | Sell |
-3
| Closed | -$41K | – | 66 |
|
|
2014
Q2 | $41K | Hold |
3
| – | – | 0.01% | 56 |
|
|
2014
Q1 | $61K | Hold |
3
| – | – | 0.02% | 66 |
|
|
2013
Q4 | $36K | Hold |
3
| – | – | 0.02% | 49 |
|
|
2013
Q3 | $40K | Hold |
3
| – | – | 0.02% | 49 |
|
|
2013
Q2 | $41K | Buy |
+3
| New | +$41K | 0.02% | 58 |
|